You are here

Nurtec ODT

Pfizer recalls migraine drug Nurtec ODT after millions of products lacked child resistant packaging

USA Today

Fri, 03/17/23 - 10:18 am

product recalls

AbbVie’s Qulipta gains ground with docs for migraine prevention, as pharma looks to pressure Biohaven’s Nurtec

Fierce Pharma

Thu, 02/10/22 - 08:02 pm

Pfizer and Biohaven close collaboration agreements

Pharmaceutical Business Review

Thu, 01/6/22 - 10:54 am

Eli Lilly, under pressure from Biohaven, launches head-to-head migraine trial between Emgality and Nurtec

Fierce Pharma

Thu, 11/18/21 - 11:03 pm

clinical trials

Buckle up AbbVie, Amgen: Biohaven's oral CGRP drug is gaining traction in migraine, doctors’ survey shows

Fierce Pharma

Fri, 10/22/21 - 12:42 pm

Biohaven migraine drug sales again top Wall Street forecasts

BioPharma Dive

Wed, 10/6/21 - 11:20 pm

Biohaven hits social media jackpot with superceleb Khloe Kardashian as spokesperson for migraine med Nurtec ODT

Fierce Pharma

Thu, 07/16/20 - 11:22 pm

celebrity endorsements

Docs 'excited' to learn more about new migraine drugs from Biohaven, Lilly and AbbVie: analyst

Fierce Pharma

Thu, 06/25/20 - 10:53 am